Background
==========

Lung cancer, including non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), is the leading cause of malignant tumor-related mortality \[[@b1-medscimonit-25-4333]\]. Epidemiological studies show that more than 1 million new cases of lung cancer and more than 800 000 deaths occur every year \[[@b2-medscimonit-25-4333],[@b3-medscimonit-25-4333]\]. The lung cancer epidemiology data from China demonstrate that the overall incidence of lung cancer in China is high, especially in Tianjin city in Dagang province and Xuanwei city in Yunnan province. The incidence of lung cancer in the above 2 areas is significantly higher than the overall global level \[[@b4-medscimonit-25-4333],[@b5-medscimonit-25-4333]\]. It is reported that 75--80% of lung cancer is NSCLC, whose biological behavior and treatment methods are different from those of small cell lung cancer. At present, the molecular mechanism of the occurrence, development, invasion, and metastasis of NSCLC is still unclear.

In recent years, with the development of gene expression profiling chip and second-generation high-throughput sequencing technology, the amount of data on lung cancer expression profiles has greatly expanded, which provides the basis for the comprehensive study of differentially expressed genes and their biological functions in lung cancer \[[@b6-medscimonit-25-4333]\]. In this study, 3 gene expression profiles of lung cancer were selected from the GEO (*<https://www.ncbi.nlm.nih.gov/geo/>*) \[[@b7-medscimonit-25-4333]\] database, and we explored the function of DEGs in the development of lung cancer and its relationship with patient prognosis.

Material and Methods
====================

Microarray data screening
-------------------------

Three gene expression data series -- GSE19804 \[[@b8-medscimonit-25-4333]\], GSE101929 \[[@b9-medscimonit-25-4333]\], and GSE33532 \[[@b10-medscimonit-25-4333]\] -- relevant to lung cancer from the GEO database were identified and included for the present analysis. The original microarry data of the 3 data series were download. For GSE19804, 120 lung cancer specimens with 60 cancer tissues and paired 60 normal lung tissues were recognized with the platform of GPL570\[HG-U133_Plus_2\] Affymetrix Human Genome U133 Plus 2.0 Array. A total of 41 non-small cell lung cancer cases were inlcuded in the data series of GSE101929 and the gene expression was detected by GPL570 \[HG-U133_Plus_2\] Affymetrix Human Genome U133 Plus 2.0 Array. For GSE33532, individual primary tumors and matched distant normal lung tissues (N) from 20 patients were used to establish gene expression patterns captured by GPL570 \[HG-U133_Plus_2\] Affymetrix Human Genome U133 Plus 2.0 Array.

Data processing
---------------

The microarray data of the included 3 data series were first analyzed using R 3.4.4 statistical software (*<https://www.r-project.org>*), then the identified dysregulated genes were further analyzed to find the overlapped genes of the 3 data series.

Biological function enrichment and pathway analysis
---------------------------------------------------

The biological function enrichment and pathways analysis were performed using the Database for Annotation, Visualization, and Integrated Discovery (DAVID, *<http://david.ncifcr.gov>*) \[[@b11-medscimonit-25-4333]\]. This analysis included 2 aspects: one is gene ontology (GO) \[[@b12-medscimonit-25-4333], [@b13-medscimonit-25-4333]\] and the other is Kyoto Encyclopedia of Genes and Genomes (KEEG) \[[@b14-medscimonit-25-4333]\]. The GO enrichment includes biological process (BP), cellular component (CC), and molecular function (MF).

Protein--protein network analysis and hub gene identification
-------------------------------------------------------------

The protein--protein network was built by the Search Tool for Retrieval of Interacting Genes (STRING) database with the criteria of: minimum required interaction score of 0.4 and active interaction sources of text mining, experiments, databases, co-expression, neighborhood, gene fusion, and co-recurrence. The target hub gene was selected with the criteria of top 10 genes according to 5 Cytohubba ranking method using Cytoscape software (*<https://cytoscape.org/>*) \[[@b15-medscimonit-25-4333]\].

Survival analysis
-----------------

The survival analysis of patients relevant to gene expression was expressed by the database of Kaplan-Meier Plotter (*<http://kmplot.com/analysis/index.php?p=background>*) \[[@b16-medscimonit-25-4333]\] through survival curves. According to the median expression of each gene in cancer tissues, the patients were divided into a high-expression group and a low-expression group. The overall survival (OS) was compared between the 2 groups for each included gene.

Results
=======

Identification of differentially expressed genes
------------------------------------------------

Datasets of GSE19804, GSE101929, and GSE33532 from the GEO database were inclued in our study. The DEGs were fist screened form each dataset, and 40 overlaping differentially expresed genes ID were identified ([Figure 1](#f1-medscimonit-25-4333){ref-type="fig"}). However, the 40 gene IDs correspond to 30 genes with 10 duplicate genes, and 1 gene ID had no gene name. Finally, 29 genes were inlcued for further analysis, of which 22 were upregulated and 7 downregulated ([Table 1](#t1-medscimonit-25-4333){ref-type="table"}). The differentially expressed genes between cancer tissue and lung normal tissue are repressented in a heat map in [Figure 2](#f2-medscimonit-25-4333){ref-type="fig"}.

GO and KEGG analysis
--------------------

The 29 dysregulated genes had gene ontology enrichment in terms of biological process (BP), cellular component (CC), and molecular function (MF). The enriched biological process was mainly related to diet-induced thermogenesis, ventricular cardiac muscle tissue morphogenesis, and brown fat cell differentiation. For the cellular component, the 29 genes were enriched in extracellular space, neuron projection, and plasma membrane. In the aspect of molecular function, only 1 term of actin filament binding was enriched. KEGG pathway analysis showed that the 29 dysregulated genes were enriched in calcium signaling pathway, regulation of lipolysis in adipocytes, and PPAR signaling pathway ([Table 2](#t2-medscimonit-25-4333){ref-type="table"}).

PPI network analysis of the 29 genes
------------------------------------

The STRING database was used for PPI network analysis, showing 79 nodes and 336 edges, with the average node degree of 8.51 ([Figure 3](#f3-medscimonit-25-4333){ref-type="fig"}), and the local clustering coefficient was 0.648. We also use Cytohubba to select the hub genes, showing that 2 downregulated genes (*MMP1 and SPP1*) were hub genes ([Figure 4](#f4-medscimonit-25-4333){ref-type="fig"}).

Survival analysis
-----------------

The prognostic significance of the 29 genes for NSCLC was analyzed in the Kaplan-Meier Plotter database. The significant difference in overall survival (OS) between upregulated and downregulated genes is shown in [Figure 5](#f5-medscimonit-25-4333){ref-type="fig"}. Twenty-two dysregulated genes were correlated with patient prognosis ([Table 3](#t3-medscimonit-25-4333){ref-type="table"}).

Discussion
==========

With the rapid development of bioinformatics, more and more microarrays and sequencing data can be publicly accessed \[[@b17-medscimonit-25-4333]\]. These data are collected and stored in corresponding databases, such as GEO (*<http://www.ncbi.nlm.nih.gov/geo>*), TCGA (*<http://www.tcga.org/>*), Kaplan-Meier Plotter, and STRING. Clinical information (e.g., disease type, age, sex, and survival rate) and gene expression data can be freely downloaded or analyzed online, providing a reliable data platform for further data mining, analysis, and solving clinical problems \[[@b18-medscimonit-25-4333],[@b19-medscimonit-25-4333]\].

The GEO database was established by the US National Library of Medicine in 2000. It is dedicated to the construction of gene expression databases and online analysis resources \[[@b20-medscimonit-25-4333]\]. It mainly contains gene chip data and partial sequencing data of various tissues. At present, it is one of the most important databases in the field of bioinformatics data mining \[[@b7-medscimonit-25-4333],[@b21-medscimonit-25-4333]\]. Fang et al. \[[@b22-medscimonit-25-4333]\] performed integrative bioinformatics analysis, revealing potential long non-coding RNA biomarkers and analysis of function in non-smoking females with lung cancer. In that study, the authors found that 2 DEGs (LINC00968 and TBX5-AS1) were associated with unfavorable prognosis in never-smoking female lung cancer patients.

In our present work, we selected data on 3 gene chips relevant to differential expression between lung cancer tissues and normal lung tissues of NSCLC patients in the GEO database. We finally identified 29 differentially expressed genes in 3 datasets and further analyzed them for biological function enrichment, pathways, and survival analysis. These 29 included dysregulated genes are mainly enriched in the biological function of diet-induced thermogenesis, ventricular cardiac muscle tissue morphogenesis, and actin filament binding. The KEGG pathway analysis showed that the 29 dysregulated genes were enriched in calcium signaling and regulation of lipolysis in adipocytes and in the PPAR signaling pathway. Further analysis showed that 2 genes (*MMP1 and SPP1*) were hub genes. Matrix metalloproteinase-1 (*MMP-1)* is part of a cluster of *MMP* genes localized to chromosome 11q22.3. *MMP-1* is involved in the breakdown of extracellular matrix, which may play an important role in tumor metastasis by breaking down interstitial collagens types I, II, and III \[[@b23-medscimonit-25-4333],[@b24-medscimonit-25-4333]\]. However, *SPP1* seems to have no correlation with cancer in terms of biological function enrichment \[[@b25-medscimonit-25-4333],[@b26-medscimonit-25-4333]\].

Our survival analysis indicated that 22 of the 29 included dysregulated genes were correlated with patient prognosis, suggesting that these 22 genes could be used as biomarkers for patient prognosis.

Conclusions
===========

Twenty-nine differently expressed genes were identified in the present work, which were enriched in the biological functions of diet-induced thermogenesis, actin filament binding, and PPAR signaling pathway. Dysregulatd genes were correlated with NSCLC patient survival and might be useful as biomarkers of prognosis. However, this conclusion needs further confirmation by laboratory experiments.
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###### 

The 29 included differentially expressed genes overlapping in GSE33532, GSE19804, and GSE101929 data series.

  Gene ID        Gene symbol   Mean logFC (GSE19804)
  -------------- ------------- -----------------------
  209612_s\_at   ADH1B         3.36491817
  229309_at      ADRB1         3.21379367
  210081_at      AGER          3.21379367
  206209_s\_at   CA4           3.86942117
  232578_at      CLDN18        4.16088183
  213317_at      CLIC5         3.45981
  204320_at      COL11A1       −3.32311183
  225681_at      CTHRC1        −3.193161
  204273_at      EDNRB         3.190866
  203980_at      FABP4         3.7473685
  209074_s\_at   FAM107A       3.4444825
  205866_at      FCN3          3.40527367
  238222_at      GKN2          3.25140117
  209469_at      GPM6A         3.61581183
  230030_at      HS6ST2        −3.390935
  204475_at      MMP1          −3.04218817
  204580_at      MMP12         −3.17540267
  239650_at      NCKAP5        3.105129
  230469_at      RTKN2         3.4138185
  205725_at      SCGB1A1       3.38117033
  214387_x\_at   SFTPC         3.2855315
  242009_at      SLC6A4        3.59241617
  213456_at      SOSTDC1       3.38619867
  206239_s\_at   SPINK1        −3.33911383
  209875_s\_at   SPP1          −4.503354
  230560_at      STXBP6        3.6274755
  219230_at      TMEM100       3.56547367
  209904_at      TNNC1         3.11718933
  204712_at      WIF1          3.77360267

###### 

GO and KEGG analysis of the differentially expressed genes between cancer tissue and lung normal tissue.

  Category           Term                                              Count   P-value
  ------------------ ------------------------------------------------- ------- ---------
  GOTERM_BP_DIRECT   Diet-induced thermogenesis                        2       9.9E-3
  GOTERM_BP_DIRECT   Ventricular cardiac muscle tissue morphogenesis   2       3.4E-2
  GOTERM_BP_DIRECT   Brown fat cell differentiation                    2       4.2E-2
  GOTERM_CC_DIRECT   Extracellular space                               6       7.7E-3
  GOTERM_CC_DIRECT   Neuron projection                                 3       1.3E-2
  GOTERM_CC_DIRECT   Plasma membrane                                   8       2.5E-2
  GOTERM_CC_DIRECT   Extracellular region                              4       3.0E-2
  GOTERM_CC_DIRECT   Collagen trimer                                   2       7.5E-2
  GOTERM_MF_DIRECT   Actin filament binding                            2       6.3E-2
  KEGG_PATHWAY       Calcium signaling pathway                         3       3.0E-2
  KEGG_PATHWAY       Regulation of lipolysis in adipocytes             2       7.7E-2
  KEGG_PATHWAY       PPAR signaling pathway                                    9.7E-2

###### 

Survival analysis of the 29 included genes.

  Gene ID        Gene symbol   HR (95% CI)          p-Value
  -------------- ------------- -------------------- ---------
  209612_s\_at   ADH1B         0.67 (0.59--0.76)    4.5E-10
  229309_at      ADRB1         0.68 (0.58--0.80)    5.2e-6
  210081_at      AGER          0.76 (0.67--0.86)    2.3e-5
  206209_s\_at   CA4           1.03 (0.9--1.165)    0.69
  232578_at      CLDN18        0.75 (0.66--0.86)    1.4E-5
  213317_at      CLIC5         0.68 (0.59--0.77)    1.3e-9
  204320_at      COL11A1       1.2 (1.02--1.42)     0.028
  225681_at      CTHRC1        1.11 (0.94--1.31)    0.21
  204273_at      EDNRB         0.72 (0.36--0.81)    2.5e-7
  203980_at      FABP4         1.02 (0.9--1.16)     0.78
  209074_s\_at   FAM107A       0.80 (0.71--0.91)    0.00078
  205866_at      FCN3          0.99 (0.87--1.12)    0.88
  238222_at      GKN2          0.83 (0.70--0.98)    0.028
  209469_at      GPM6A         0.74 (0.65--0.84)    2.9e-6
  230030_at      HS6ST2        0.75 (0.64--0.89)    0.00071
  204475_at      MMP1          1.07 (0.94--1.21)    0.30
  204580_at      MMP12         1.52 (1.34--1.73)    9.1e-11
  239650_at      NCKAP5        0.64 (0.54--0.76)    1.6e-7
  230469_at      RTKN2         1.02 ()0.86--1.20    0.85
  205725_at      SCGB1A1       0.81 (0.71--0.92)    0.0012
  214387_x\_at   SFTPC         0.81 (0.71--0.92)    0.0011
  242009_at      SLC6A4        0.74 (0.63--0.87)    0.00035
  213456_at      SOSTDC1       1.07 (0.94--1.21)    0.32
  206239_s\_at   SPINK1        0.765 (0.67--0.86)   1.5e-5
  209875_s\_at   SPP1          1.32 (1.16--1.49)    1.9e-5
  230560_at      STXBP6        0.77 (0.65--0.91)    0.0017
  219230_at      TMEM100       0.62 (0.54--0.71)    1.2e-13
  209904_at      TNNC1         1.28 (1.13--1.45)    0.00014
  204712_at      WIF1          0.67 (0.59--0.76)    3.2e-10
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